Autotransfusion Devices Market to Exhibit a CAGR of 6.6% over 2025 to 2032; Rising Demand for Advanced Blood Management Systems to Bolster Industry Expansion

The global autotransfusion devices market size stood at USD 309.7 million in 2024. The market value is slated to rise from USD 329.6 million in 2025 to USD 516.9 million by 2032 at a CAGR of 6.6% during 2025-2032. Fortune Business Insights™ presents this information in its report titled “Autotransfusion Devices Market Size, Share & Industry Analysis, By Product Type (Autotransfusion Systems {Intraoperative, Post-operative, and Dual-Mode} and Consumables & Accessories), By Application (Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics & Gynecological Surgeries, and Others), By End User (Hospitals and Specialty Clinics & Others), and Regional Forecast, 2025-2032”.

During surgeries, autotransfusion devices help in the process of autotransfusion which helps people use their own blood instead of relying on donated blood. The demand for advanced blood management systems is rising with the increasing geriatric population and a rise in the number of surgical procedures.

The onset of the COVID-19 pandemic negatively affected the product demand, resulting in a drop in the revenues of several industry players in 2020. For instance, LivaNova PLC recorded nearly 11.5% decline in 2020 compared to 2019 driven by a downturn in product sales.

LivaNova Announced Plans to Participate in Stifel and other Healthcare Conferences to Enhance Business Prospects

In November 2024, LivaNova PLC shared plans to participate in various health conferences in November and December to provide a general business update during fireside chats. The company would be participating in the Stifel Healthcare Conference 2024 and the 6^th Annual Wolfe Research Healthcare Conference in November and the Piper Sandler Healthcare Conference in December. The move is anticipated to help the company enhance its business prospects.

Soaring Technological Advancements to Bode well for Industry Growth

The escalating emphasis of industry players and research institutes to develop and bring novel and advanced products to the market. In addition, several companies are introducing novel platforms to bolster product adoption, positively influencing autotransfusion devices market growth.

The high cost of these systems may, however, affect industry expansion.

Key Players Adopt Various Strategic Steps to Enhance their Global Market Presence

Major industry participants are deploying numerous strategies to increase their global market presence. The introduction of new autotransfusion devices, portfolio expansion, and collaborations are some of these initiatives. Besides, companies are acquiring other players to gain a strong market foothold.

Key Players Profiled in the Report

• LivaNova PLC (U.K.)
• Medtronic (Ireland)
• Haemonetics Corporation (U.S.)
• Fresenius SE & Co. KGaA (Germany)
• BD (Becton, Dickinson, and Company) (U.S.)
• Beijing Jingjing Medical Equipment Co., Ltd. (China)
• ProCell Surgical Inc. (U.S.)

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/autotransfusion-devices-market-101899

Key Industry Development

• March 2023 – Haemonetics Corporation secured the U.S. FDA’s 510 (k) clearance on next-generation software for the Cell Saver Elite+ Autotransfusion System.

Further Report Findings

• The rising usage of autotransfusion devices in major surgical procedures is anticipated to push industry expansion in North America. In 2024, the regional market held a dominant share. The U.S. records an escalating number of transplantations and surgeries, which boosts product demand in the country.
• The Europe market is expanding with mounting awareness of the benefits of using autotransfusion devices. Furthermore, the region records a rapid escalation in the number of surgeries in major countries such as Germany, France, and the U.K.
• On the basis of product type, consumables & accessories segment registered a leading market share in 2024 owing to the rising product deployment in various surgical procedures.
• Based on application, in 2024, the cardiovascular surgeries segment held a key autotransfusion devices market share impelled by the soaring number of cardiovascular procedures such as Coronary Artery Bypass Grafting (CABG), heart transplantations, implantable cardioverter-defibrillator (ICD) & pacemaker implantations, and valve replacement surgeries.
• By end user, hospitals segment garnered a major market share in 2024 fueled by the rising number of hospitals in emerging and developed countries and rising number of cardiovascular and obstetrics & gynecological surgeries in the hospitals.    

Table of Segmentation